Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Phase of Trial: Phase III
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Dalteparin sodium (Primary) ; Enoxaparin sodium; Heparin; Warfarin
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Adverse reactions; Therapeutic Use
- Acronyms Kids-DOTT
- 21 Mar 2017 Planned End Date changed from 1 Dec 2020 to 30 Jun 2022.
- 21 Mar 2017 Planned primary completion date changed from 1 Dec 2019 to 30 Jun 2021.
- 30 Jan 2013 Planned number of patients changed from 1250 to 750 as reported by ClinicalTrials.gov.